The IGF2BP3 gene helps cells manage RNA messages, which are the working copies of genetic instructions used to make proteins at the right time. It is especially active during early growth and development, where it supports how cells grow, move, and mature. When this gene’s activity is out of balance, cells may behave less predictably, and higher activity has been linked more often to cancer biology than to a single inherited condition. IGF2BP3 is mainly known in medical research and cancer care rather than through major public awareness campaigns.
What is a gene?
Genes are stretches of DNA that provide cells with instructions to make molecules or regulate processes in the body. Some genes carry the directions for producing proteins, the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they take place, and how strongly they run. As a group, genes affect how the body develops and functions, and they can also shape your response to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
IGF2BP3Gene function
What if the gene works
The IGF2BP3 gene helps cells control how certain genetic messages are used to make proteins. This supports normal growth, development, and cell movement, especially before birth.
Risk
What if the gene does not work
Changes in the IGF2BP3 gene can weaken or alter how cells handle RNA messages, affecting when certain growth related proteins are made. Milder variants may cause subtle effects, while more severe variants can disrupt this control more strongly.
Treatment
What does that mean for your treatment
No IGF2BP3-specific treatment or drug selection approach is currently established in clinical guidelines. In cancer research, the IGF2BP3 gene is being studied mainly as a biomarker and possible drug target because altered activity, rather than inherited loss-of-function variants, may influence tumor behavior.
Gene function
What if the gene works
Your cells use the IGF2BP3 gene to manage important RNA messages after DNA has already been read. Its protein attaches to selected messenger RNA, the working copies of genetic instructions, and helps control how long those messages last, where they travel, and when they are used. Knowing what the IGF2BP3 gene does in the body helps explain how cells coordinate growth and development.
The IGF2BP3 gene makes a protein that recognizes and attaches to selected messenger RNA, the working copies of genetic instructions. This helps cells sort and handle some messages differently from others.
By holding onto certain RNA messages, this gene can help protect them from being broken down too soon. That gives cells a steadier supply of instructions for making needed proteins.
IGF2BP3 also helps control when bound messages are used to build proteins. This timing step supports more coordinated protein making during normal cell activity.
Its protein can guide RNA messages to the parts of a cell where they are needed. This helps protein making happen in the right place, which supports organized cell function.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IGF2BP3 gene can change the shape, stability, or amount of the protein, which may weaken RNA binding or alter its interactions with other cell molecules. In how IGF2BP3 gene variants affect protein function, milder changes may only slightly reduce activity, while more disruptive variants can truncate the protein, disrupt key binding regions, or lead to faster breakdown inside the cell. Some variants may also affect RNA splicing, creating an altered protein with less predictable behavior.
How variants are linked to conditions
Variants in the IGF2BP3 gene do not yet have a broadly confirmed link to a specific health condition, and information about IGF2BP3 gene variants and disease risk is still developing. If you have a confirmed IGF2BP3 gene finding, the most useful guidance comes from your doctor or genetic counselor, who can interpret it in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and instead reflect normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a definitive diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IGF2BP3 gene. Anyone with concerns about personal or family risk can talk with a doctor or genetic counselor.
Inheritance of IGF2BP3 variants
There is not yet a broadly confirmed inheritance pattern tied to a specific human condition for the IGF2BP3 gene, so how IGF2BP3 gene variants are inherited in a disease causing way is still being worked out. The IGF2BP3 gene is located on chromosome 7, which is an autosome. That means each person usually has two copies of this gene, with one inherited from each parent.
What does my IGF2BP3 result mean for my family?
There isn’t yet a broadly confirmed inherited pattern tied to a specific genetic condition for IGF2BP3, though this can change as research grows. If you have a specific IGF2BP3 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To find out if you have an IGF2BP3 variant, a lab can analyze DNA from a blood or saliva sample, or sometimes tissue, using genetic sequencing. This kind of IGF2BP3 genetic testing reads the gene’s code and compares it with the usual sequence to identify variants that may help explain a result in the right clinical context.
When should I consider getting a genetic test?
There is not yet a broadly established IGF2BP3-specific reason for genetic testing in routine care. Testing decisions are usually based on your personal health history, family history, and whether a doctor or genetic counselor thinks broader genetic testing would be helpful.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies by the condition and the type of variant involved. Age, lifestyle, environment, and medical history are among the factors that shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results may help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or reacts to it at its target. This helps explain why the same treatment may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in a person’s genes can affect their response to medications. It examines gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can help support treatment choices that are both more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the IGF2BP3 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects they may cause. If you have concerns about a medicine, side effects, or how treatment is affecting you, speak with your doctor or pharmacist.
History
In the late 1990s and early 2000s, researchers identified the IGF2BP3 gene as part of a small family of genes that bind RNA, the cell’s working copies of genetic instructions. It was also named IMP3, and that name became widely used in pathology research. Early studies drew attention to IGF2BP3 because it is active during fetal development and then often reappears in several cancers. From these first observations, research expanded steadily, and IGF2BP3 became better known as a laboratory marker that can help pathologists study certain tumors. Over time, descriptions became more precise as scientists linked older naming systems and newer genetic data. Today, its history is mainly tied to cancer research and diagnostic pathology rather than public awareness.